In collaboration with the UK CURE Alliance we offer pilot funding for multidisciplinary research related to the novel virus.
By leveraging our existing infrastructure and collaborating with the UK CURE Alliance, we rapidly launched a pilot funding program for research projects in three areas. Applications are accepted on a rolling basis. Full-time faculty in all title series at the University of Kentucky are eligible to apply.
Questions can be directed to Joel Thompson, PhD, CCTS Research Development Director, at email@example.com.
- Jeremy Wood, PhD, UK College of Medicine
Project: Dissecting the Underlying Mechanisms of Hemostatic Dysregulation in COVID-19 Patients
Louis Hersh, PhD, and David Rodgers, PhD UK College of Medicine
Project: Production of Single Chain Antibodies (Nanobodies) to SARS-CoV-2 Spike Glycoprotein and its Receptor Binding Domain
Steven Van Lanen, PhD, UK College of Pharmacy
Project: RNA-Dependent RNA Polymerase as an Antiviral Target
Jerold Woodward, PhD, and Siva Gandhapudi, PhD, UK College of Medicine
Project: Identification and Characterization of Virus Specific T Cells in Humans Exposed to SARS-COV-2
Emphasis is on applications that have an impact on the evolving COVID-19 pandemic in the following areas:
- Basic science approaches on SARS-CoV-2 and its receptor, animal models of COVID-19, risk factors and their direct association with COVID-19
- Clinical research involving the diagnosis, treatment, prevention and a better understanding of the epidemiology of COVID-19
- Community impact of COVID-19. It is likely that these studies will promote team science and involve in the investigating team a professional with knowledge of the pandemic and/or its causative agent SARS-CoV-2 (e.g. clinician, epidemiologist, etc)
- High impact on expanding knowledge or developing new knowledge on the COVID-19 pandemic and SARS-CoV-2.
It is an expectation that these funds will be used to obtain preliminary data for an extramural grant submission related to COVID-19/SARS-CoV-2.
Proposals are reviewed on an ongoing basis by members of the UK CURE COVID-19 Review Committee and funding decisions are made based on scientific merit, relevance to program goals, and potential for extramural support.